Relationship between PASI and DLQI scores and anxiety/depression in patients with moderate-to-severe psoriasis treated with brodalumab in the AMAGINE-1 trial

被引：0
|
作者：
Chiricozzi, A. [1 ]
Faurby, M. [2 ]
Hansen, J. [2 ]
Nielsen, V. Schultz [2 ]
Lacour, J. -P. [3 ]
机构：
[1] Univ Pisa, Dept Dermatol, Pisa, Italy
[2] LEO Pharma, Ballerup, Denmark
[3] Nice Univ Hosp, Archet Hosp 2, Dept Dermatol, Nice, France
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷
关键词：
Brodalumab; HADS; Psoriasis;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P112
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] Improvements in depression and anxiety with brodalumab therapy in AMAGINE-1, a phase 3 study for moderate to severe plaque psoriasis
    Papp, Kim
    Reich, Kristian
    Paul, Carle
    Blauvelt, Andrew
    Toth, Darryl
    Langley, Richard G.
    Cather, Jennifer
    Gottlieb, Alice
    Li, Joanne
    Kricorian, Gregory
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB254 - AB254
  • [2] Improvements in patient-reported outcomes (PROs) among moderate to severe plaque psoriasis patients treated with brodalumab: Results from AMAGINE-1
    Strober, Bruce
    Gordon, Kenneth
    Augustin, Matthias
    Viswanathan, Hema
    Klekotka, Paul
    Milmont, Cassandra
    Kricorian, Gregory
    Harrison, David
    Pinto, Lionel
    Nirula, Ajay
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB256 - AB256
  • [3] COMPARING DERMATOLOGY LIFE QUALITY INDEX (DLQI) BETWEEN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS AND MODERATE-TO-SEVERE PSORIASIS PATIENTS
    Kim, Yeong Ho
    Yoo, Seung Ah
    Han, Ju Hee
    Lee, Ji Hae
    Bang, Chul Hwan
    Lee, Young Bok
    Kim, Jung Eun
    Park, Hyun Jung
    Park, Chul Jong
    Lee, Ji Hyun
    Cho, Sang Hyun
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 20 - 20
  • [4] Efficacy and Safety of Brodalumab In Patients With Moderate To Severe Plaque Psoriasis: Results of AMAGINE-1, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Papp, K.
    Reich, K.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Gottlieb, A. B.
    Thaci, D.
    Li, J.
    Nirula, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [5] IMPACT OF DEPRESSION AND ANXIETY ON EMPLOYABILITY AND PRODUCTIVITY IN PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS
    Reich, K.
    Han, C.
    Szapary, P.
    Yeilding, N.
    Ortonne, J. P.
    Schenkel, B.
    Langley, R.
    VALUE IN HEALTH, 2009, 12 (07) : A527 - A527
  • [6] Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-Blind, placebo-controlled study
    Papp, Kim
    Reich, Kristian
    Leonardi, Craig
    Paul, Carle
    Blauvelt, Andrew
    Baran, Wojciech
    Bolduc, Chantal
    Toth, Darryl
    Langley, Richard G.
    Cather, Jennifer
    Gottlieb, Alice
    Thaci, Diamant
    Milmont, Cassandra E.
    Lim, Joanne
    Klekotka, Paul
    Kricorian, Greg
    Nirula, Ajay
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [7] Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab
    Lambert, Jo
    Hansen, Jes Birger
    Sohrt, Anne
    Puig, Luis
    DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1265 - 1275
  • [8] Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab
    Jo Lambert
    Jes Birger Hansen
    Anne Sohrt
    Luis Puig
    Dermatology and Therapy, 2021, 11 : 1265 - 1275
  • [9] Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)
    Blauvelt, Andrew
    Papp, Kim A.
    Lebwohl, Mark G.
    Green, Lawrence J.
    Hsu, Sylvia
    Bhatt, Varsha
    Rastogi, Shipra
    Pillai, Radhakrishnan
    Israel, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (02) : 372 - 374
  • [10] Analysis of Body Regions and Components of PASI Scores During Adalimurnab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis
    Navarini, Alexander A.
    Poulin, Yves
    Menter, Alan
    Gu, Yihua
    Teixeira, Henrique D.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (05) : 554 - 562
12345